Lanean...
Modeling the interaction between danoprevir and mericitabine in the treatment of chronic HCV infection
Modeling HCV RNA decline kinetics under therapy has proven useful for characterizing treatment effectiveness. Here we model HCV viral kinetics (VK) in 72 patients given a combination of danoprevir, a protease inhibitor and mericitabine, a nucleoside polymerase inhibitor for 14 days in the INFORM-1 t...
Gorde:
| Argitaratua izan da: | Antivir Ther |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4862948/ https://ncbi.nlm.nih.gov/pubmed/26555159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP3006 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|